Premature myocardial infarction is associated with low serum levels of Wnt-1

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 251-256

  Goliasch, Georg ^a   Wiesbauer, Franz ^a   Kastl, Stefan P ^a,b   Katsaros, Katharina M ^a,b   Blessberger, Hermann ^a   Maurer, Gerald ^a   Schillinger, Martin ^a   Huber, Kurt ^c   Wojta, Johann ^a,b   Speidl, Walter S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Foundation for Cardiovascular Research   (Austria)

^c Cardiology and Emergency Medicine   (Austria)

Author keywords

Premature myocardial infarction; Risk factors; Wnt

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; DICKKOPF 1 PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREMATURE MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; SURVIVOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOCARDIAL INFARCTION; WNT SIGNALING PATHWAY; WNT1 PROTEIN;

EID: 84859842928     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.017     Document Type: Article

References (41)

1. Malmberg K., Bavenholm P., Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol 1994, 24:592-599.
2. Fournier J.A., Cabezon S., Cayuela A., et al. Long-term prognosis of patients having acute myocardial infarction when
3. Choudhury L., Marsh J.D. Myocardial infarction in young patients. Am J Med 1999, 107:254-261.
4. Wiesbauer F., Blessberger H., Azar D., et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age). Eur Heart J 2009, 30:1073-1079.
5. Goliasch G., Wiesbauer F., Grafl A., et al. The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (
6. Mani A., Radhakrishnan J., Wang H., et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007, 315:1278-1282.
7. Manolagas S.C., Almeida M. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol 2007, 21:2605-2614.
8. Couffinhal T., Dufourcq P., Duplaa C. Beta-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation?. Circ Res 2006, 99:1287-1289.
9. Rao T.P., Kuhl M. An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 2010, 106:1798-1806.
10. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
11. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
12. Gherghe C.M., Duan J., Gong J., et al. Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner. FASEB J: Official Publication of the Federation of American Societies for Experimental Biology 2011, 25:1836-1843.
13. Assmus B., Iwasaki M., Schachinger V., et al. Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur Heart J 2011.
14. Dupont W.D., Plummer W.D. Power and sample size calculations. A review and computer program. Control Clin Trials 1990, 11:116-128.
15. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 1995, 289-300.
16. Liu W., Mani S., Davis N.R., et al. Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance. Circ Res 2008, 103:1280-1288.
17. Sarzani R., Salvi F., Bordicchia M., et al. Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant. Nutr Metab Cardiovasc Dis 2011, 21:150-156.
18. Brack A.S., Conboy M.J., Roy S., et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810.
19. Grant S.F., Thorleifsson G., Reynisdottir I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323.
20. Horikawa Y., Iwasaki N., Hara M., et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 1997, 17:384-385.
21. Scott L.J., Mohlke K.L., Bonnycastle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
22. Abiola M., Favier M., Christodoulou-Vafeiadou E., et al. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One 2009, 4:e8509.
23. Wright W.S., Longo K.A., Dolinsky V.W., et al. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 2007, 56:295-303.
24. Fujino T., Asaba H., Kang M.J., et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 2003, 100:229-234.
25. Magoori K., Kang M.J., Ito M.R., et al. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 2003, 278:11331-11336.
26. Wang R., Ahmed J., Wang G., et al. Down-regulation of the canonical Wnt beta-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD. PLoS One 2011, 6:e14793.
27. Wang X., Xiao Y., Mou Y., et al. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 2002, 90:340-347.
28. Ezan J., Leroux L., Barandon L., et al. FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. Cardiovasc Res 2004, 63:731-738.
29. Essers M.A., de Vries-Smits L.M., Barker N., et al. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 2005, 308:1181-1184.
30. Shao J.S., Cheng S.L., Pingsterhaus J.M., et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005, 115:1210-1220.
31. Samarzija I., Sini P., Schlange T., et al. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun 2009, 386:449-454.
32. Dejana E. The role of wnt signaling in physiological and pathological angiogenesis. Circ Res 2010, 107:943-952.
33. Bergmann M.W. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res 2010, 107:1198-1208.
34. Aisagbonhi O., Rai M., Ryzhov S., et al. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis Model Mech 2011, 4:469-483.
35. Christman M.A., Goetz D.J., Dickerson E., et al. Wnt5a is expressed in murine and human atherosclerotic lesions. Am J Physiol Heart Circ Physiol 2008, 294:H2864-H2870.
36. Blumenthal A., Ehlers S., Lauber J., et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006, 108:965-973.
37. Ueland T., Otterdal K., Lekva T., et al. Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29:1228-1234.
38. Duan J., Gherghe C., Liu D., et al. Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J 2011, 31:429-442.
39. Laeremans H., Hackeng T.M., van Zandvoort M.A., et al. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 2011, 124:1626-1635.
40. Oikonomopoulos A., Sereti K.I., Conyers F., et al. Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res 2011, 109:1363-1374.
41. Perez Castrillon J.L., San Miguel A., Vega G., et al. Levels of DKK1 in patients with acute myocardial infarction and response to atorvastatin. Int J Cardiol 2010, 145:164-165.